Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg EP News Bureau May 9, 2025 Being the exclusive first-to-file, Lupin is eligible for 180-day generic exclusivity
Lupin gains tentative USFDA nod for Sitagliptin and Metformin Hydrochloride Tablets EP News Bureau Nov 29, 2024 Sitagliptin and Metformin Hydrochloride tablets to market a generic equivalent of Janumet tablets of Merck Sharp & Dohme
